128 related articles for article (PubMed ID: 32389607)
1. MPA given orally during the first trimester for threatened miscarriage carries no specific risk for foetal abnormalities albeit the rate is higher than non-threatened pregnancies.
Yovich JL; Mariappen U; Hinchliffe PM; Dhaliwal SS; Keane KN
Reprod Biol; 2020 Sep; 20(3):424-432. PubMed ID: 32389607
[TBL] [Abstract][Full Text] [Related]
2. Medroxyprogesterone acetate therapy in early pregnancy has no apparent fetal effects.
Yovich JL; Turner SR; Draper R
Teratology; 1988 Aug; 38(2):135-44. PubMed ID: 3175947
[TBL] [Abstract][Full Text] [Related]
3. Use of oral progestogen in women with threatened miscarriage in the first trimester: a randomized double-blind controlled trial.
Chan DMK; Cheung KW; Ko JKY; Yung SSF; Lai SF; Lam MT; Ng DYT; Lee VCY; Li RHW; Ng EHY
Hum Reprod; 2021 Feb; 36(3):587-595. PubMed ID: 33331637
[TBL] [Abstract][Full Text] [Related]
4. Maternal and perinatal outcome in women with threatened miscarriage in the first trimester: a systematic review.
Saraswat L; Bhattacharya S; Maheshwari A; Bhattacharya S
BJOG; 2010 Feb; 117(3):245-57. PubMed ID: 19943827
[TBL] [Abstract][Full Text] [Related]
5. Obstetric outcome in women with threatened miscarriage in the first trimester.
Wijesiriwardana A; Bhattacharya S; Shetty A; Smith N; Bhattacharya S
Obstet Gynecol; 2006 Mar; 107(3):557-62. PubMed ID: 16507924
[TBL] [Abstract][Full Text] [Related]
6. Medroxyprogesterone acetate does not perturb the profile of steroid metabolites in urine during pregnancy.
Yovich JL; Willcox DL; Wilkinson SP; Poletti VM; Hähnel R
J Endocrinol; 1985 Mar; 104(3):453-9. PubMed ID: 3156203
[TBL] [Abstract][Full Text] [Related]
7. Obstetric outcome after threatened miscarriage with and without a hematoma on ultrasound.
Johns J; Hyett J; Jauniaux E
Obstet Gynecol; 2003 Sep; 102(3):483-7. PubMed ID: 12962928
[TBL] [Abstract][Full Text] [Related]
8. Serum progesterone distribution in normal pregnancies compared to pregnancies complicated by threatened miscarriage from 5 to 13 weeks gestation: a prospective cohort study.
Ku CW; Allen JC; Lek SM; Chia ML; Tan NS; Tan TC
BMC Pregnancy Childbirth; 2018 Sep; 18(1):360. PubMed ID: 30185145
[TBL] [Abstract][Full Text] [Related]
9. Threatened miscarriage as a predictor of obstetric outcome.
Johns J; Jauniaux E
Obstet Gynecol; 2006 Apr; 107(4):845-50. PubMed ID: 16582121
[TBL] [Abstract][Full Text] [Related]
10. Influence of threatened miscarriage on pregnancy and early postpartum period: a case-control report.
Ozdemirci S; Karahanoglu E; Esinler D; Gelisen O; Kayıkcıoglu F
J Matern Fetal Neonatal Med; 2015 Jul; 28(10):1186-9. PubMed ID: 25053196
[TBL] [Abstract][Full Text] [Related]
11. The effects of threatened abortions on pregnancy outcomes.
Kanmaz AG; İnan AH; Beyan E; Budak A
Ginekol Pol; 2019; 90(4):195-200. PubMed ID: 30901073
[TBL] [Abstract][Full Text] [Related]
12. The outcome of pregnancies in 182 women with threatened miscarriage.
Basama FM; Crosfill F
Arch Gynecol Obstet; 2004 Sep; 270(2):86-90. PubMed ID: 12682847
[TBL] [Abstract][Full Text] [Related]
13. Chinese herbal medicines for threatened miscarriage.
Li L; Dou L; Leung PC; Wang CC
Cochrane Database Syst Rev; 2012 May; (5):CD008510. PubMed ID: 22592730
[TBL] [Abstract][Full Text] [Related]
14. Changes in total and free concentrations of steroid hormones in the plasma of women throughout pregnancy: effects of medroxyprogesterone acetate in the first trimester.
Willcox DL; Yovich JL; McColm SC; Schmitt LH
J Endocrinol; 1985 Nov; 107(2):293-300. PubMed ID: 2933480
[TBL] [Abstract][Full Text] [Related]
15. A retrospective population-based study of primigravid women on the potential effect of threatened miscarriage on obstetric outcome.
Mulik V; Bethel J; Bhal K
J Obstet Gynaecol; 2004 Apr; 24(3):249-53. PubMed ID: 15203618
[TBL] [Abstract][Full Text] [Related]
16. Threatened abortion and late-pregnancy complications: a case-control study and review of literature.
Petriglia G; Palaia I; Musella A; Marchetti C; Antonilli M; Brunelli R; Ostuni R; Benedetti Panici P
Minerva Ginecol; 2015 Dec; 67(6):491-7. PubMed ID: 25668506
[TBL] [Abstract][Full Text] [Related]
17. Dydrogesterone support in threatened miscarriage.
El-Zibdeh MY; Yousef LT
Maturitas; 2009 Dec; 65 Suppl 1():S43-6. PubMed ID: 20007011
[TBL] [Abstract][Full Text] [Related]
18. [The incidence of congenital abnormalities following gestagen administration in early pregnancy (author's transl)].
Schneider WH; Philipp K; Schmid R
Wien Klin Wochenschr; 1981 Dec; 93(23):711-2. PubMed ID: 7342466
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of progesterone on threatened miscarriage: an updated meta-analysis of randomized trials.
Yan Y; Chen Z; Yang Y; Zheng X; Zou M; Cheng G; Yuan Z
Arch Gynecol Obstet; 2021 Jan; 303(1):27-36. PubMed ID: 32989508
[TBL] [Abstract][Full Text] [Related]
20. Threatened miscarriage and depressive and anxiety symptoms among women and partners in early pregnancy.
Zhu CS; Tan TC; Chen HY; Malhotra R; Allen JC; Østbye T
J Affect Disord; 2018 Sep; 237():1-9. PubMed ID: 29754019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
